Jennison Associates LLC Savara Inc Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Savara Inc stock. As of the latest transaction made, Jennison Associates LLC holds 5,731,480 shares of SVRA stock, worth $21.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,731,480
Previous 8,841,971
35.18%
Holding current value
$21.6 Million
Previous $44 Million
47.55%
% of portfolio
0.01%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding SVRA
# of Institutions
147Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$92 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$54.8 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$46.5 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$30.7 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$30.2 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $429M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.